INSM (STOCKS)
Insmed, Inc.
$151.310000
-3.500000 (-2.26%)
Prev close: $154.810000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- William H. Lewis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $32,582.84M
- Employees
- 1,271
- P/E (TTM)
- -23.60
- P/B (TTM)
- 44.89
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
16
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.54 | $-1.32 | -0.2236 | -16.99% |
|
Sep 2025 (Q3)
|
$-1.75 | $-1.37 | -0.3838 | -28.09% |
|
Jun 2025 (Q2)
|
$-1.70 | $-1.32 | -0.3808 | -28.87% |
|
Mar 2025 (Q1)
|
$-1.42 | $-1.36 | -0.0607 | -4.47% |
Financial Statements
| Revenues | $606.42M |
| Benefits Costs and Expenses | $1.88B |
| Cost Of Revenue | $122.94M |
| Costs And Expenses | $1.85B |
| Gross Profit | $483.49M |
| Operating Expenses | $1.73B |
| Selling, General, and Administrative Expenses | $701.17M |
| Research and Development | $771.09M |
| Other Operating Expenses | $257.99M |
| Operating Income/Loss | -$1.25B |
| Income/Loss From Continuing Operations After Tax | -$1.28B |
| Income/Loss From Continuing Operations Before Tax | -$1.27B |
| Income Tax Expense/Benefit | $5.03M |
| Income Tax Expense/Benefit, Current | $5.05M |
| Income Tax Expense/Benefit, Deferred | -$27.00K |
| Interest Expense, Operating | $83.80M |
| Net Income/Loss | -$1.28B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$1.28B |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.28B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.42 |
| Diluted Earnings Per Share | -$6.42 |
| Basic Average Shares | 199,014,000 |
| Diluted Average Shares | 199,014,000 |
| Assets | $2.26B |
| Current Assets | $1.79B |
| Inventory | $132.07M |
| Other Current Assets | $1.66B |
| Noncurrent Assets | $470.35M |
| Fixed Assets | $102.94M |
| Other Non-current Assets | $367.41M |
| Liabilities | $1.53B |
| Current Liabilities | $468.87M |
| Accounts Payable | $79.91M |
| Wages | $111.51M |
| Other Current Liabilities | $277.45M |
| Noncurrent Liabilities | $1.06B |
| Long-term Debt | $546.77M |
| Other Non-current Liabilities | $509.94M |
| Equity | $738.98M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $738.98M |
| Liabilities And Equity | $2.26B |
| Net Cash Flow From Operating Activities | -$935.01M |
| Net Cash Flow From Operating Activities, Continuing | -$935.01M |
| Net Cash Flow From Investing Activities | -$64.58M |
| Net Cash Flow From Investing Activities, Continuing | -$64.58M |
| Net Cash Flow From Financing Activities | $954.07M |
| Net Cash Flow From Financing Activities, Continuing | $954.07M |
| Exchange Gains/Losses | $931.00K |
| Net Cash Flow | -$44.59M |
| Net Cash Flow, Continuing | -$45.52M |
| Comprehensive Income/Loss | -$1.27B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$1.27B |
| Other Comprehensive Income/Loss | -$1.27B |
| Other Comprehensive Income/Loss Attributable To Parent | $3.75M |